Testosterone propionate /
testosterone ketolaurate
Combination of
Testosterone propionateAndrogen; Anabolic steroid
Testosterone ketolaurateAndrogen; Anabolic steroid
Clinical data
Trade namesTestosid-Depot
Other namesTP/TKL
Routes of
administration
Intramuscular injection

Testosterone propionate/testosterone ketolaurate (TP/TKL), sold under the brand name Testosid-Depot, is an injectable combination medication of testosterone propionate (TP), an androgen/anabolic steroid, and testosterone ketolaurate (TKL; testosterone caprinoylacetate), an androgen/anabolic steroid.[1][2][3][4][5] It contains 25 mg TP and 150 to 300 mg TKL in oil solution and is administered by intramuscular injection at regular intervals.[3][4][5] The medication has been reported to have a duration of action of about 14 to 20 days.[5]

Parenteral durations of androgens/anabolic steroids
MedicationFormMajor brand namesDuration
TestosteroneAqueous suspensionAndronaq, Sterotate, Virosterone2–3 days
Testosterone propionateOil solutionAndroteston, Perandren, Testoviron3–4 days
Testosterone phenylpropionateOil solutionTestolent8 days
Testosterone isobutyrateAqueous suspensionAgovirin Depot, Perandren M14 days
Mixed testosterone estersaOil solutionTriolandren10–20 days
Mixed testosterone estersbOil solutionTestosid Depot14–20 days
Testosterone enanthateOil solutionDelatestryl14–28 days
Testosterone cypionateOil solutionDepovirin14–28 days
Mixed testosterone esterscOil solutionSustanon 25028 days
Testosterone undecanoateOil solutionAveed, Nebido100 days
Testosterone buciclatedAqueous suspension20 Aet-1, CDB-1781e90–120 days
Nandrolone phenylpropionateOil solutionDurabolin10 days
Nandrolone decanoateOil solutionDeca Durabolin21–28 days
MethandriolAqueous suspensionNotandron, Protandren8 days
Methandriol bisenanthoyl acetateOil solutionNotandron Depot16 days
Metenolone acetateOil solutionPrimobolan3 days
Metenolone enanthateOil solutionPrimobolan Depot14 days
Note: All are via i.m. injection. Footnotes: a = TP, TV, and TUe. b = TP and TKL. c = TP, TPP, TiCa, and TD. d = Studied but never marketed. e = Developmental code names. Sources: See template.

See also

References

  1. Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 642–. ISBN 978-1-4757-2085-3.
  2. Kimmig J (14 March 2013). Therapie der Haut- und Geschlechtskrankheiten. Springer-Verlag. pp. 507–. ISBN 978-3-642-94850-3.
  3. 1 2 Hellbrügge T, Opitz H, Schmid F (14 December 2013). Pädiatrische Therapie. Springer-Verlag. pp. 303–. ISBN 978-3-662-34511-5.
  4. 1 2 Arends G, Zörnig H, Hager H, Frerichs G, Kern W (14 December 2013). Hagers Handbuch der pharmazeutischen Praxis: Für Apotheker, Arzneimittelhersteller, Drogisten, Ärzte u. Medizinalbeamte. Springer-Verlag. pp. 1145–. ISBN 978-3-662-36329-4.
  5. 1 2 3 Schuermann H, Doepfmer R (1960). Fertilitätsstörungen beim Manne. Springer-Verlag. pp. 260–. ISBN 978-3-642-94784-1.



This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.